Veronica Manicardi

7PUBLICATIONS
28CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 13, 2026
MDM2 Drives Proteasome Inhibitor Resistance and Represents a TP53-Independent Therapeutic Vulnerability in Multiple Myeloma.

|Apr 27, 2026
Sphingosine-1-Phosphate Promotes FOS Activation in Osteosarcoma Under Tumor Acidosis.

|Jun 27, 2024
Molecular and Histopathological Characterization of Metastatic Cutaneous Squamous Cell Carcinomas: A Case-Control Study.

Alessia Paganelli, Marco Zaffonato, Benedetta Donati

|Jul 06, 2023
Ex vivo mapping of enhancer networks that define the transcriptional program driving melanoma metastasis.

Veronica Manicardi, Mila Gugnoni, Elisabetta Sauta

|May 16, 2023
Euchromatic Histone Lysine Methyltransferase 2 Inhibition Enhances Carfilzomib Sensitivity and Overcomes Drug Resistance in Multiple Myeloma Cell Lines.

Elisabetta Mereu, Damiano Abbo, Tina Paradzik

|Mar 11, 2023
An Innovative Drug Repurposing Approach to Restrain Endometrial Cancer Metastatization.

Federica Torricelli, Elisabetta Sauta, Veronica Manicardi

Pageof 2

Frequent Collaborators

5 joint publications

Alessia Ciarrocchi

3 joint publications

Benedetta Donati

2 joint publications

Mila Gugnoni

2 joint publications

Elisabetta Sauta